Inhalers used to treat COPD carry no excess cardiovascular risk – a finding that could finally quash long-held concerns about use of the drugs in COPD patients who also have cardiovascular disease. Researchers from the SUMMIT trial – the largest COPD outcome trial and the first to specifically enrol patients with, or at greater risk ...
COPD inhalers not linked to an increase in cardiovascular risk
By Sunalie Silva
4 May 2017